Conference Reports for NATAP
EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026
Back
Long-term treatment with elafibranor improves markers of immune
response and inflammation in primary biliary cholangitis
EASL 2026 May 26-30 Barcelona
David Jones,1
